A detailed history of Journey Strategic Wealth LLC transactions in Organon & Co. stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 12,970 shares of OGN stock, worth $260,956. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,970
Previous 13,229 1.96%
Holding current value
$260,956
Previous $190,000 27.89%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $3,569 - $4,869
-259 Reduced 1.96%
12,970 $243,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $144,857 - $229,126
13,229 New
13,229 $190,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Journey Strategic Wealth LLC Portfolio

Follow Journey Strategic Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.